Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Indian Journal of Forensic Medicine & Toxicology
Asaad Hasan Noaman1 , Amina A. B. Al-Dejeli2 and Falah Mahdi Dananah
Unknown Affiliation
Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Mean Circumferential Fibers Shortening Velocity Assessment in Patients with type II Diabetes Mellitus in relation to their Diastolic Function Status Asaad Hasan Noaman1 , Amina A. B. Al-Dejeli2 and Falah Mahdi Dananah
Indian Journal of Forensic Medicine & Toxicology Vol. 14 No. 4 (2020): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v14i4.11583

Abstract

Background: The most important cause of death in diabetic patients is the cardiac insult. Mean circumferentialfibers shortening velocity (MCFSV) was used to detect the systolic cardiac dysfunction.Objective: This study aimed to evaluate MCFSV in people who have Type 2 diabetes.Patients and methods: This analytic observational study was performed in Al-Furat teaching hospital.Eighty type 2 diabetics were involved in this study. All patients were subjected to traditional Dopplermeasures: tissue Doppler-derived E/E,and MCFSV.Results: Echocardiographic measures revealed 35 subjects having Grade I of Diastolic dysfunction (DD), 15having Grade II while 10 were diagnosed with Grade III of this condition. MCFSV did not change in patientswith normal diastolic function (0.00137±2.02) and those with grade I diastolic dysfunction (0.00148±3.5),(P value: 0.2) while significant reduction was documented in patients with grade II diastolic dysfunction(0.0011±9.1, P value: 0.00) and grade III diastolic dysfunction (0.001±6.02, P value: 0.00)Conclusions: There is a connection between Reduction of MCFSV and increased grading of diastolicdysfunction (DD) in type II diabetics.
Co-Authors